What are the recommended dosing guidelines for Cialis (tadalafil) for erectile dysfunction, including starting dose, dose adjustments, daily regimen, maximum dose, and contraindications?

Cialis (Tadalafil) Dosing for Erectile Dysfunction

For most men with erectile dysfunction, start with Cialis 10 mg taken as needed prior to sexual activity, with dose adjustment to 20 mg or 5 mg based on response and tolerability. 1

As-Needed (PRN) Dosing

Standard Dosing

• Starting dose: 10 mg taken prior to anticipated sexual activity 2, 1
• Dose adjustment: May increase to 20 mg or decrease to 5 mg based on individual efficacy and tolerability 2, 1
• Maximum frequency: Once per day in most patients 1
• Duration of effect: Improves erectile function up to 36 hours following dosing 1

Key Prescribing Instructions

• Sexual stimulation is required for the medication to work—this is a common cause of treatment failure 2
• Multiple trials may be necessary to establish efficacy; one failed attempt does not indicate treatment failure 2
• Timing with food: May be taken without regard to meals 1
• Dose titration is essential: Work with the patient to find the optimal dose that balances efficacy with acceptable side effects 2

Once-Daily Dosing

For Erectile Dysfunction Alone

• Starting dose: 2.5 mg taken at approximately the same time every day 1
• Dose adjustment: May increase to 5 mg based on individual efficacy and tolerability 1
• Timing: Without regard to timing of sexual activity 1

The once-daily regimen produces similar efficacy to as-needed dosing, with 12-week studies showing IIEF-EF domain score increases of 6.2 points with 2.5 mg and 8.6 points with 5 mg versus 1.3 points for placebo 3. Successful intercourse rates reached 50% with 2.5 mg and 62% with 5 mg daily versus 33% for placebo 3.

For Benign Prostatic Hyperplasia (BPH) or ED/BPH

• Dose: 5 mg taken at approximately the same time every day 1
• When initiating BPH treatment with Cialis and finasteride, use 5 mg daily for up to 26 weeks 1

Dose Adjustments for Special Populations

Renal Impairment

For As-Needed Dosing:

• CrCl 30-50 mL/min: Start with 5 mg, maximum 10 mg not more than once every 48 hours 1
• CrCl <30 mL/min or hemodialysis: Maximum 5 mg not more than once every 72 hours 1

For Once-Daily Dosing:

• CrCl <30 mL/min or hemodialysis: Once-daily dosing is NOT recommended for ED alone 1
• CrCl 30-50 mL/min (for BPH or ED/BPH): Start with 2.5 mg, may increase to 5 mg based on response 1

Hepatic Impairment

For As-Needed Dosing:

• Mild to moderate (Child-Pugh A or B): Maximum 10 mg once per day 1
• Severe (Child-Pugh C): Use is NOT recommended 1

For Once-Daily Dosing:

• Use with caution in mild to moderate hepatic impairment; not extensively evaluated 2

Concomitant Medications

• With potent CYP3A4 inhibitors (ketoconazole, ritonavir):
  • As-needed: Maximum 10 mg every 72 hours 1
  • Once-daily: Maximum 2.5 mg 1

Special Clinical Scenarios

Testosterone Deficiency

• PDE5 inhibitors are more effective when combined with testosterone therapy in hypogonadal men 2
• Testosterone alone is NOT effective monotherapy for ED 2

Diabetes Mellitus

• Men with diabetes have more severe ED at baseline and respond less robustly to PDE5 inhibitors 2
• In diabetic patients, both 2.5 mg and 5 mg daily dosing significantly improved IIEF-EF scores (increases of 4.8 and 4.5 points respectively) with successful intercourse rates >40% 3
• Daily 5 mg may provide superior improvement in ejaculatory function compared to on-demand 20 mg in diabetic patients 4

Post-Prostatectomy

• Men post-prostatectomy have more severe ED and respond less robustly to PDE5 inhibitors 2
• Long-term tadalafil 5 mg once daily can be effective for penile rehabilitation after nerve-sparing radical prostatectomy 5
• Patients with venogenic ED show poorer responses (14.2%) compared to those with arteriogenic ED (55.0%) 5

Non-Responders to Initial PDE5 Inhibitor Therapy

• Verify appropriate medication use and timing before declaring treatment failure 6
• Education about proper dosing and need for sexual stimulation can restore effectiveness 6
• Consider switching between PDE5 inhibitors, though evidence is limited 6
• In men with incomplete response to maximum-dose as-needed PDE5 inhibitors, switching to tadalafil 5 mg once daily resulted in 39-40% achieving normal erectile function (IIEF-EF ≥26) versus 12% with placebo 7

Contraindications

Absolute Contraindications

• Concurrent use of organic nitrates in any form (tadalafil potentiates hypotensive effects) 1
• Concurrent use of guanylate cyclase stimulators (e.g., riociguat) 1
• History of serious hypersensitivity reaction to tadalafil 1

Relative Contraindications and Cautions

• Cardiovascular status: Do not use if sexual activity is inadvisable 1
• Alpha-blockers: Use with caution for ED; NOT recommended in combination for BPH treatment due to inadequate efficacy data and hypotension risk 1
• Antihypertensives or substantial alcohol (≥5 units): May lead to hypotension 1
• Priapism risk factors: Use with caution in patients predisposed to priapism 1
• History of NAION: Use with caution only when benefits outweigh risks 1

Common Adverse Events

The most common adverse events (≥2%) include headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and limb pain 1. Adverse events follow a dose-response pattern, with higher doses associated with increased rates 2. Tadalafil has the lowest rates of flushing among PDE5 inhibitors 2.

Critical Safety Warnings

• Erection lasting >4 hours: Seek emergency treatment immediately 1
• Sudden vision loss: Stop medication and seek medical care (possible NAION) 1
• Sudden hearing loss: Stop medication and seek prompt medical attention 1